This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Published Erratum

. 2019 Sep 21;40(36):3043.

doi: 10.1093/eurheartj/ehz630.

Corrigendum to: Uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation: the ELIMINATE-AF trial

No authors listed

PMID: 31504419
PMCID: PMC6754568
DOI: 10.1093/eurheartj/ehz630

Published Erratum

Corrigendum to: Uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation: the ELIMINATE-AF trial

No authors listed. Eur Heart J. 2019.

. 2019 Sep 21;40(36):3043.

doi: 10.1093/eurheartj/ehz630.

PMID: 31504419
PMCID: PMC6754568
DOI: 10.1093/eurheartj/ehz630

No abstract available

PubMed Disclaimer

Erratum for

Uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation: the ELIMINATE-AF trial.
Hohnloser SH, Camm J, Cappato R, Diener HC, Heidbüchel H, Mont L, Morillo CA, Abozguia K, Grimaldi M, Rauer H, Reimitz PE, Smolnik R, Mönninghoff C, Kautzner J. Hohnloser SH, et al. Eur Heart J. 2019 Sep 21;40(36):3013-3021. doi: 10.1093/eurheartj/ehz190. Eur Heart J. 2019. PMID: 30976787 Free PMC article. Clinical Trial.

Publication types

Actions

LinkOut - more resources

Full Text Sources